Blood Tests for Alzheimer's Are Here New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments--such as monoclonal antibodies--sooner. Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer's disease. Tau is one of two proteins, the other being amyloid, that become malformed and accumulate in the brains of patients with certain types of dementia. It is believed that the buildup of these proteins interferes with the communication of brain cells, leading to these patients' symptoms. The test had already received authorization in July for marketing in Europe and is thus the first early screening system for Alzheimer's for use in primary care settings approved in the planet's two major pharmaceutical markets.

This article explores the extension of well-known F1 score used for assessing the performance of binary classifiers. We propose the new metric using probabilistic interpretation of precision, recall, specificity, and negative predictive value. We describe its properties and compare it to common metrics. Then we demonstrate its behavior in edge cases of the confusion matrix. Finally, the properties of the metric are tested on binary classifier trained on the real dataset.

In recent years, the global Internet of Medical Things (IoMT) industry has evolved at a tremendous speed. Security and privacy are key concerns on the IoMT, owing to the huge scale and deployment of IoMT networks. Machine learning (ML) and blockchain (BC) technologies have significantly enhanced the capabilities and facilities of healthcare 5.0, spawning a new area known as "Smart Healthcare." By identifying concerns early, a smart healthcare system can help avoid long-term damage. This will enhance the quality of life for patients while reducing their stress and healthcare costs. The IoMT enables a range of functionalities in the field of information technology, one of which is smart and interactive health care. However, combining medical data into a single storage location to train a powerful machine learning model raises concerns about privacy, ownership, and compliance with greater concentration. Federated learning (FL) overcomes the preceding difficulties by utilizing a centralized aggregate server to disseminate a global learning model. Simultaneously, the local participant keeps control of patient information, assuring data confidentiality and security. This article conducts a comprehensive analysis of the findings on blockchain technology entangled with federated learning in healthcare. 5.0. The purpose of this study is to construct a secure health monitoring system in healthcare 5.0 by utilizing a blockchain technology and Intrusion Detection System (IDS) to detect any malicious activity in a healthcare network and enables physicians to monitor patients through medical sensors and take necessary measures periodically by predicting diseases.

ATLANTA -- An ultrasound-based artificial intelligence classifier of thyroid nodules identified benign nodules with sensitivity similar to fine-needle aspiration, according to data presented at ENDO 2022. "Artificial analysis of thyroid ultrasound images can identify nodules that are very unlikely to be malignant," Nikita Pozdeyev, MD, PhD, assistant professor at University of Colorado Anschutz Medical Campus, told Healio. "These are mostly spongiform nodules that have a less than 3% probability of malignancy." Pozdeyev and colleagues trained a supervised deep learning classifier of thyroid nodules on 32,545 images of 621 thyroid nodules acquired from University of Washington. The classifier was then tested on an independent set of 145 nodules collected from the University of Colorado.

In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our collective computational power rapidly increasing, vast amounts of data and our ability to assimilate it, has seeded unprecedented fertile ground for innovation. Healthtech companies are rapidly sprouting from data ridden soil at exponential rates. Cell free DNA companies, once a rarity, are becoming ubiquitous. The genomics landscape, once dominated by the few, are being inundated by a slew of competitors. Grandiose claims of being able to diagnose 50 different cancers from a single blood sample, or use AI to best dermatologists, radiologists, pathologists, etc., are being made at alarming rates. Accordingly, it's imperative to know how to assess these claims as fact or fiction, particularly when such claimants may employ "statistical misdirection". In this addition to "The Insider's Guide to Translational Medicine" we disarm perpetrators of statistical warfare of their greatest ...

"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. To develop an artificial intelligence (AI)-based model to detect mitral regurgitation (MR) from chest radiographs. This retrospective study included echocardiography and associated chest radiographs consecutively collected at our institution between July 2016 and May 2019.

An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a rapid, reliable COVID-19 screening test to rule out COVID-19 infection. The AI-enhanced EKG was able to detect COVID-19 infection in the test with a positive predictive value -- people infected -- of 37% and a negative predictive value -- people not infected -- of 91%. When additional normal control subjects were added to reflect a 5% prevalence of COVID-19 -- similar to a real-world population -- the negative predictive value jumped to 99.2%. The findings are published in Mayo Clinic Proceedings.

The article, "AI-Enabled ECG Improves Ability to Identify Heart Failure in Emergency Departments," was originally published on Practical Cardiology. An artificial intelligence (AI)-enabled electrocardiogram (ECG) could aid clinicians in emergency departments more accurately identify heart failure. Findings from the study indicate the AI-enhanced ECG could improve identification of left ventricular systolic dysfunction in patients presenting the emergency departments with acute dyspnea. "AI-enhanced ECGs are quicker and outperform current standard-of-care tests. Our results suggest that high-risk cardiac patients can be identified quicker in the emergency department and provides an opportunity to link them early to appropriate cardiovascular care," said lead investigator Demilade Adedinsewo, MD, MPH, chief fellow in the division of cardiovascular medicine at Mayo Clinic in Jacksonville, Florida, in a statement.

In this paper, we study a bi-criterion framework for assessing scoring functions in the context of binary classification. The positive and negative predictive values (ppv and npv, respectively) are conditional probabilities of the true label matching a classifier's predicted label. The usual classification error rate is a linear combination of these probabilities, and therefore, concentration inequalities for the error rate do not yield confidence intervals for the two separate predictive values. We study generalization properties of scoring functions with respect to predictive values by deriving new distribution-free large deviation and uniform convergence bounds. The latter bound is stated in terms of a measure of function class complexity that we call the order coefficient; we relate this combinatorial quantity to the VC-subgraph dimension.

According to the American Diabetes Association(ADA), 30.3 million people in the United States have diabetes, but only 7.2 million may be undiagnosed and unaware of their condition. Type 2 diabetes is usually diagnosed for most patients later on in life whereas the less common Type 1 diabetes is diagnosed early on in life. People can live healthy and happy lives while living with diabetes, but early detection produces a better overall outcome on most patient's health. Thus, to test the accurate prediction of Type 2 diabetes, we use the patients' information from an electronic health records company called Practice Fusion, which has about 10,000 patient records from 2009 to 2012. This data contains individual key biometrics, including age, diastolic and systolic blood pressure, gender, height, and weight. We use this data on popular machine learning algorithms and for each algorithm, we evaluate the performance of every model based on their classification accuracy, precision, sensitivity, specificity/recall, negative predictive value, and F1 score. In our study, we find that all algorithms other than Naive Bayes suffered from very low precision. Hence, we take a step further and incorporate all the algorithms into a weighted average or soft voting ensemble model where each algorithm will count towards a majority vote towards the decision outcome of whether a patient has diabetes or not. The accuracy of the Ensemble model on Practice Fusion is 85\%, by far our ensemble approach is new in this space. We firmly believe that the weighted average ensemble model not only performed well in overall metrics but also helped to recover wrong predictions and aid in accurate prediction of Type 2 diabetes. Our accurate novel model can be used as an alert for the patients to seek medical evaluation in time.